News
MNM Diagnostics received Certificate of Approval to the standards ISO 9001:2015, which means we meet requirements of the management standards in the organization in the field of : "Banking and…
Katarzyna Tylak27 July 2021
MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients. To date, we…
Katarzyna Tylak14 May 2021
Research indicating the genetic background of the severe illness in COVID-19 cases, co-authored by Dr. Paweł Zawadzki from MNM Diagnostics and the Polish Biobanking Center, was among the most remarkable…
[email protected]13 January 2021
Patients of the Polish Mother's Memorial Hospital Research Institute in Łódź have gained access to a cancer diagnosis method based on tumor DNA analysis. ICZMP signed an agreement on this…
[email protected]13 January 2021
BioFuture is a Conference, where pioneers, innovators and entrepreneurs gather to be part of the discussions that will shape and transform the future of healthcare. One can say that the…
Katarzyna Cieśla19 October 2021